These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1729767)
1. Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents. Keller BJ; Yamanaka H; Thurman RG Toxicology; 1992; 71(1-2):49-61. PubMed ID: 1729767 [TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity due to clofibrate is oxygen-dependent in the perfused rat liver. Keller BJ; Yamanaka H; Liang DC; Thurman RG Toxicol Appl Pharmacol; 1990 Jun; 104(2):259-66. PubMed ID: 2363177 [TBL] [Abstract][Full Text] [Related]
3. O2-dependent hepatotoxicity due to ethylhexanol in the perfused rat liver: mitochondria as a site of action. Keller BJ; Yamanaka H; Liang DC; Kauffman FC; Thurman RG J Pharmacol Exp Ther; 1990 Mar; 252(3):1355-60. PubMed ID: 2319471 [TBL] [Abstract][Full Text] [Related]
4. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat. Graham MJ; Winham MA; Old SL; Gray TJ Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300 [TBL] [Abstract][Full Text] [Related]
5. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes. Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation. Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105 [TBL] [Abstract][Full Text] [Related]
7. Effects of joint exposures to selected peroxisome proliferators on hepatic acyl-CoA oxidase activity in male B6C3F1 mice. Ochs JB; Baldwin LA; Leonard DA; Calabrese EJ Hum Exp Toxicol; 1992 Mar; 11(2):83-8. PubMed ID: 1349224 [TBL] [Abstract][Full Text] [Related]
8. Effects of clofibric and beclobric acid in rat and monkey hepatocyte primary culture: influence on peroxisomal and mitochondrial beta-oxidation and the activity of catalase, glutathione S-transferase and glutathione peroxidase. Mennes WC; Wortelboer HM; Hassing GA; van Sandwijk K; Timmerman A; Schmid BP; Jahn U; Blaauboer BJ Arch Toxicol; 1994; 68(8):506-11. PubMed ID: 7802591 [TBL] [Abstract][Full Text] [Related]
9. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate. Foliot A; Touchard D; Mallet L Biochem Pharmacol; 1986 May; 35(10):1685-90. PubMed ID: 3707598 [TBL] [Abstract][Full Text] [Related]
11. The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle. MacDonald RS; Swan PB Biochim Biophys Acta; 1986 Feb; 880(2-3):153-60. PubMed ID: 3942787 [TBL] [Abstract][Full Text] [Related]
12. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Blaauboer BJ; van Holsteijn CW; Bleumink R; Mennes WC; van Pelt FN; Yap SH; van Pelt JF; van Iersel AA; Timmerman A; Schmid BP Biochem Pharmacol; 1990 Aug; 40(3):521-8. PubMed ID: 2383284 [TBL] [Abstract][Full Text] [Related]
13. Induction of peroxisomal enzymes in cultured porcine endothelial cells by the hypolipidemic drug ciprofibrate. Glauert HP; Hennig B; Chow HS J Biochem Toxicol; 1990; 5(2):115-8. PubMed ID: 2283660 [TBL] [Abstract][Full Text] [Related]
14. Expression of liver peroxisomal proteins as compared to other organelle marker enzymes in rats treated with hypolipidemic agents. Cherkaoui Malki M; Bardot O; Lhuguenot JC; Latruffe N Biol Cell; 1990; 69(2):83-92. PubMed ID: 2271901 [TBL] [Abstract][Full Text] [Related]
15. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245 [TBL] [Abstract][Full Text] [Related]
16. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver. Bojes HK; Thurman RG Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448 [TBL] [Abstract][Full Text] [Related]
17. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation. Rao MS; Subbarao V Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675 [TBL] [Abstract][Full Text] [Related]
18. Peroxisomal enzyme activities in brain and liver of pups of lactating mothers treated with ciprofibrate. Singh I; Lazo O Neurosci Lett; 1992 Apr; 138(2):283-6. PubMed ID: 1608540 [TBL] [Abstract][Full Text] [Related]
19. Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators. Cherkaoui Malki M; Lone YC; Corral-Debrinski M; Latruffe N Biochem Biophys Res Commun; 1990 Dec; 173(3):855-61. PubMed ID: 2268348 [TBL] [Abstract][Full Text] [Related]
20. The effect of peroxisome proliferators on mitochondrial bioenergetics. Zhou S; Wallace KB Toxicol Sci; 1999 Mar; 48(1):82-9. PubMed ID: 10330687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]